What are the proposed changes in specificity/selectivity as per the Draft ICH guideline -Q2(R2)
19:35
What are the proposed changes in the REPORTABLE RANGE as per the Draft ICH guideline -Q2(R2)
32:41
Performance Characteristic: Validation of Analytical procedures as per ICH
1:15:45
EURECA-PRO Invited Lecture by Harald Raupenstrauch (Univ of Leoben, Austria) on 15.11.2024 [camera]
16:08
How to Conduct Forced Degradation Study for Drug Product as per ANVISA?
15:30
General Considerations For Validation Of Analytical Procedures As Per ICH Guideline Q2(R2)
12:26
What are the differences in method validation between ICH and ANVISA?
21:21
METHOD VALIDATION | REPORTABLE RANGE FOR IMPURITIES AS PER ICH Q2(R2)
17:09